The NSW government-funded RNA Research and Pilot Manufacturing Facility at Macquarie University will start producing its first product batches this year. The facility was borne out of a $100 million government commitment in 2021, as Covid was still playing havoc with supply chains. In this episode of the Commercial Disco, RNA Australia CEO Paul McDonald talks about the genesis of the program – and how it will help build generations of commercial treatments and therapeutics.
